• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MMWR Morb Mortal Wkly Rep . Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020

tetano

Editor, Senior Moderator
MMWR Morb Mortal Wkly Rep


. 2021 Jan 15;70(2):56-57.
doi: 10.15585/mmwr.mm7002e3.
Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020

Christopher Prestel, Erica Anderson, Kaitlin Forsberg, Meghan Lyman, Marie A de Perio, David Kuhar, Kendra Edwards, Maria Rivera, Alicia Shugart, Maroya Walters, Nychie Q Dotson

Abstract

In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward.
 
Back
Top Bottom